Health Canada to introduce new Regulatory Enrolment Process (REP) for Medical Devices effective January 2026

As a leading provider of medical device regulatory strategy services to innovative MedTech firms BML Health continuously monitors all key announcements and evolving requirements from Health Canada, and other major regulatory agencies worldwide.  For these reasons we are informing MedTech companies presently engaged with Health Canada, or planning to do so in the future, of an […]